Discover
INTS
Intensity Therapeutics, Inc.
3.40
2 x 2.67
2 x 4.46
bid
ask
+
0.06
1.80%
2 @ 04:00 PM
3.40 +0.00 (0.00%)
| Ytd | -66.83% | |
| 1y | -89.70% |
3.21
day range
3.46
3.00
52 week range
28.75
| Open | 3.40 | Prev Close | 3.34 | Low | 3.21 | High | 3.46 | Mkt Cap | 11.10M |
| Vol | 16.11K | Avg Vol | 25.19K | EPS | -3.89 | P/E | N/A | Forward P/E | -1.66 |
| Beta | N/A | Short Ratio | 3.05 | Inst. Own | 12.49% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-07 | 50-d Avg | 3.80 | 200-d Avg | 5.26 | 1yr Est | 10.00 |
| Income Statement | |||
| Operating Expenses | 3.08M | ||
| Research and Development Expense | 1.83M | ||
| Selling, General and Administrative Expense | 1.25M | ||
| Operating Income | -3.08M | ||
| Net Income | -3.01M | ||
| Net Income Common Stock | -3.01M | ||
| Net Income Common Stock (USD) | -3.01M | ||
| Consolidated Income | -3.01M | ||
| Earnings per Basic Share | -1.11 | ||
| Earnings per Basic Share (USD) | -1.11 | ||
| Earnings per Diluted Share | -1.11 | ||
| Earning Before Interest & Taxes (EBIT) | -3.01M | ||
| Earning Before Interest & Taxes (USD) | -3.01M | ||
| Weighted Average Shares | 2.71M | ||
| Weighted Average Shares Diluted | 2.71M | ||
| Balance Sheet | |||
| Cash and Equivalents | 9.53M | ||
| Cash and Equivalents (USD) | 9.53M | ||
| Current Assets | 11.23M | ||
| Property, Plant & Equipment Net | 82.00K | ||
| Total Assets | 11.52M | ||
| Total Debt | 62.00K | ||
| Current Liabilities | 2.25M | ||
| Debt Non-Current | 62.00K | ||
| Total Liabilities | 2.31M | ||
| Accumulated Retained Earnings (Deficit) | -83.83M | ||
| Shareholders Equity | 9.21M | ||
| Shareholders Equity (USD) | 9.21M | ||
| Assets Non-Current | 292.00K | ||
| Total Debt (USD) | 62.00K | ||
| Liabilities Non-Current | 62.00K | ||
| Trade and Non-Trade Payables | 1.01M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 7.00K | ||
| Net Cash Flow from Financing | 1.62M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -716.00K | ||
| Issuance (Purchase) of Equity Shares | 1.62M | ||
| Net Cash Flow from Operations | -2.34M | ||
| Share Based Compensation | 387.00K | ||